Background illustration for clinical trials search

Paid Clinical Trials Norwalk

Discover 1,132 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: New Haven CT, Boston MA, Fairfax VA, Pittsburgh PA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase1, Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

for
Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Location: New Haven CT, New York NY, Chapel Hill NC, Milwaukee WI,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT06656494

Phase1, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, The Bronx NY, Baltimore MD, Columbus OH,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase1, Recruiting

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06100705

Phase2, Recruiting

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: New Haven CT, New York NY, Rochester NY, Detroit MI,
Sponsor: Panbela Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05254171

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Madison WI, Houston TX, Seattle WA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06625593

Phase1, Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Boston MA, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase1, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: New Haven CT, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase1, Phase2, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early_phase1, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: New Haven CT, The Bronx NY, New York NY, Fairfax VA,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase1, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: New Haven CT, New York NY, Baltimore MD, Buffalo NY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase2, Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: New Haven CT, New York NY, Providence RI, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05902988

Phase1, Phase2, Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase3, Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: New Haven CT, New York NY, Philadelphia PA, Boston MA,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase1, Phase2, Recruiting

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

for
Neoplasm, Cancer, Malignant Tumors
Location: New Haven CT, Boston MA, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd

Sex: All

Age: 18+

Code: NCT06759649

Phase1, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: New Haven CT, New York NY, Philadelphia PA, Boston MA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase1, Phase2, Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for
Advanced Solid Tumor, PDAC, HNSCC
Location: New Haven CT, New York NY, Boston MA, St Louis MO,
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06597721

Phase1, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: New Haven CT, New York NY, Hackensack NJ, Morristown NJ,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: New Haven CT, Pittsburgh PA, Dallas TX, Duarte CA,
Sponsor: RefleXion Medical

Sex: All

Age: 0+

Code: NCT05406167

Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, New Brunswick NJ, Boston MA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06385080

Phase1, Phase2, Recruiting